Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
IMPG2	50939	broad.mit.edu	37	3	100951720	100951720	+	Missense_Mutation	SNP	T	T	G			STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	g.chr3:100951720T>G	ENST00000193391.7	-	15	3325	c.3138A>C	c.(3136-3138)gaA>gaC	p.E1046D		NM_016247.3	NP_057331.2	Q9BZV3	IMPG2_HUMAN	interphotoreceptor matrix proteoglycan 2	1046	EGF-like 1.	NA			visual perception	integral to membrane|proteinaceous extracellular matrix	extracellular matrix structural constituent|heparin binding|hyaluronic acid binding|receptor activity			NS(1)|breast(2)|cervix(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(3)|kidney(2)|large_intestine(14)|lung(32)|ovary(2)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	64						AGGGCCGTTCTTCCACACTCA	0.502		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													110	97	102	NA		NA	NA	3		NA											NA				100951720		2203	4300	6503	SO:0001583	missense			ENSG00000081148	HGNC:18362		Approved	uc003duq.2	NA	A8MWT5|Q9UKD4|Q9UKK5	ENST00000193391.7	37	CCDS2940.1	.	.	.	.	.	.	.	.	.	.	T	4.485	0.089917	0.08632	.	.	ENSG00000081148	ENST00000193391;ENST00000417518	T	0.22134	1.97	5.88	0.639	0.17747	EGF-like region, conserved site (1);Epidermal growth factor-like, type 3 (1);	0.580398	0.17919	N	0.157580	T	0.03651	0.0104	N	0.00760	-1.21	0.27904	N	0.938877	B;B	0.06786	0.001;0.001	B;B	0.04013	0.001;0.001	T	0.32955	-0.9887	10	0.02654	T	1	-1.5159	0.5675	0.00689	0.3883:0.1402:0.1814:0.2902	.	1046;1046	F1T0J3;Q9BZV3	.;IMPG2_HUMAN	D	1046;6	ENSP00000193391:E1046D	ENSP00000193391:E1046D	E	-	3	2	IMPG2	102434410	0.620000	0.27068	0.997000	0.53966	0.983000	0.72400	-0.257000	0.08745	-0.114000	0.11936	-0.411000	0.06167	GAA	IMPG2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000353256.3	51.434798	KEEP		-	52.40738	0.352941	18	33	---	---	---	---	1	1	34	79	0	127	19	35	0	104	2	TP
ZBTB20	26137	broad.mit.edu	37	3	114069396	114069396	+	Missense_Mutation	SNP	G	G	A			STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	g.chr3:114069396G>A	ENST00000462705.1	-	11	2131	c.1310C>T	c.(1309-1311)gCc>gTc	p.A437V	ZBTB20-AS1_ENST00000496219.1_RNA|ZBTB20_ENST00000471418.1_Missense_Mutation_p.A437V|ZBTB20_ENST00000357258.3_Missense_Mutation_p.A437V|ZBTB20_ENST00000481632.1_Missense_Mutation_p.A437V|ZBTB20-AS1_ENST00000467304.1_RNA|ZBTB20_ENST00000464560.1_Missense_Mutation_p.A437V|ZBTB20_ENST00000393785.2_Missense_Mutation_p.A437V|ZBTB20-AS1_ENST00000475939.1_RNA|ZBTB20_ENST00000474710.1_Missense_Mutation_p.A510V	NM_001164343.1	NP_001157815.1	Q9HC78	ZBT20_HUMAN	zinc finger and BTB domain containing 20	510		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(1)|central_nervous_system(1)|endometrium(10)|kidney(2)|large_intestine(8)|lung(15)|ovary(4)|pancreas(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(2)	48				LUSC - Lung squamous cell carcinoma(41;0.0581)|Lung(219;0.191)		AGTGAAGAGGGCTGGCAGGTA	0.612		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(69;748 1344 9802 11203 30933)							NA				0													70	57	62	NA		NA	NA	3		NA											NA				114069396		2203	4300	6503	SO:0001583	missense			ENSG00000181722	HGNC:13503	NM_015642	Approved	uc003ebi.3	NA	Q63HP6|Q8N6R5|Q9Y410	ENST00000462705.1	37	CCDS2981.1	.	.	.	.	.	.	.	.	.	.	G	15.77	2.932796	0.52866	.	.	ENSG00000181722	ENST00000462705;ENST00000393785;ENST00000481632;ENST00000471418;ENST00000474710;ENST00000357258;ENST00000464560	T;T;T;T;T;T;T	0.10573	2.86;2.86;2.86;2.86;2.86;2.86;2.86	5.68	5.68	0.88126	.	0.056925	0.64402	D	0.000001	T	0.07954	0.0199	N	0.08118	0	0.58432	D	0.999994	B	0.26363	0.147	B	0.21917	0.037	T	0.36065	-0.9763	10	0.48119	T	0.1	.	19.7986	0.96495	0.0:0.0:1.0:0.0	.	510	Q9HC78	ZBT20_HUMAN	V	437;437;437;437;510;437;437	ENSP00000420324:A437V;ENSP00000377375:A437V;ENSP00000418092:A437V;ENSP00000419902:A437V;ENSP00000419153:A510V;ENSP00000349803:A437V;ENSP00000417307:A437V	ENSP00000349803:A437V	A	-	2	0	ZBTB20	115552086	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	9.219000	0.95173	2.682000	0.91365	0.557000	0.71058	GCC	ZBTB20-006	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000354954.1	37.222051	KEEP		-	40.43983	0.254237	15	44	---	---	---	---	1	1	173	304	0	336	16	54	0	137	2	TP
PIK3CA	5290	broad.mit.edu	37	3	178936091	178936091	+	Missense_Mutation	SNP	G	G	A	rs104886003		STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	g.chr3:178936091G>A	ENST00000263967.3	+	10	1790	c.1633G>A	c.(1633-1635)Gag>Aag	p.E545K		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	545	PI3K helical.	NA	E -> A (in cancer).|E -> G (in KERSEB).|E -> K (in KERSEB; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N-terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation; enhances invadopodia-mediated extracellular matrix degradation and invasion in breast cancer cells).		epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.E545K(881)|p.E545Q(18)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			TGAAATCACTGAGCAGGAGAA	0.353	E545K(BC3C_URINARY_TRACT)|E545K(BFTC909_KIDNEY)|E545K(DLD1_LARGE_INTESTINE)|E545K(ESS1_ENDOMETRIUM)|E545K(HCC202_BREAST)|E545K(HCT15_LARGE_INTESTINE)|E545K(HSC4_UPPER_AERODIGESTIVE_TRACT)|E545K(HT1197_URINARY_TRACT)|E545K(HUH28_BILIARY_TRACT)|E545K(KYSE510_OESOPHAGUS)|E545K(L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|E545K(MCF7_BREAST)|E545K(MDAMB361_BREAST)|E545K(MKN1_STOMACH)|E545K(NCIH460_LUNG)|E545K(NCIH508_LARGE_INTESTINE)|E545K(NCIH596_LUNG)|E545K(RERFLCSQ1_LUNG)|E545K(TCCSUP_URINARY_TRACT)|E545K(TE5_OESOPHAGUS)	57	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	899	Substitution - Missense(899)	breast(308)|large_intestine(286)|urinary_tract(97)|lung(44)|endometrium(37)|ovary(25)|stomach(17)|upper_aerodigestive_tract(16)|skin(14)|central_nervous_system(13)|cervix(13)|thyroid(7)|oesophagus(7)|penis(4)|kidney(3)|soft_tissue(2)|pancreas(2)|haematopoietic_and_lymphoid_tissue(1)|biliary_tract(1)|NS(1)|pituitary(1)											61	60	60	NA		NA	NA	3		NA											NA				178936091		1813	4072	5885	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	NA	Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	36	5.703347	0.96812	.	.	ENSG00000121879	ENST00000263967	T	0.63255	-0.03	5.78	5.78	0.91487	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.73822	0.3636	L	0.51914	1.62	0.80722	D	1	D	0.62365	0.991	D	0.62955	0.909	T	0.68872	-0.5294	10	0.32370	T	0.25	-25.7963	20.0024	0.97423	0.0:0.0:1.0:0.0	.	545	P42336	PK3CA_HUMAN	K	545	ENSP00000263967:E545K	ENSP00000263967:E545K	E	+	1	0	PIK3CA	180418785	1.000000	0.71417	1.000000	0.80357	0.951000	0.60555	9.476000	0.97823	2.722000	0.93159	0.467000	0.42956	GAG	PIK3CA-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348409.2	46.859713	KEEP		+	47.548742	0.369565	17	29	---	---	---	---	1	1	167	310	2	398	23	36	0	97	9	TP
PAX6	5080	broad.mit.edu	37	11	31822286	31822286	+	Missense_Mutation	SNP	C	C	T			STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	g.chr11:31822286C>T	ENST00000419022.1	-	8	986	c.518G>A	c.(517-519)cGc>cAc	p.R173H	PAX6_ENST00000379107.2_Missense_Mutation_p.R173H|PAX6_ENST00000241001.8_Missense_Mutation_p.R159H|PAX6_ENST00000379111.2_Missense_Mutation_p.R159H|PAX6_ENST00000379115.4_Missense_Mutation_p.R173H|PAX6_ENST00000379123.5_Missense_Mutation_p.R159H|PAX6_ENST00000533156.1_5'Flank|PAX6_ENST00000379129.2_Missense_Mutation_p.R173H|PAX6_ENST00000379132.3_Missense_Mutation_p.R159H	NM_001127612.1|NM_001258462.1|NM_001258463.1	NP_001121084.1|NP_001245391.1|NP_001245392.1	P26367	PAX6_HUMAN	paired box 6	159	Gln/Gly-rich.	NA			blood vessel development|central nervous system development|cornea development in camera-type eye|glucose homeostasis|iris morphogenesis|negative regulation of neurogenesis|neuron fate commitment|pancreatic A cell development|positive regulation of transcription, DNA-dependent|response to wounding|visual perception	cytoplasm|nuclear chromatin	R-SMAD binding|RNA polymerase II core promoter sequence-specific DNA binding|sequence-specific DNA binding RNA polymerase II transcription factor activity|ubiquitin-protein ligase activity			central_nervous_system(2)|endometrium(2)|kidney(2)|large_intestine(7)|lung(15)|ovary(3)|pancreas(1)|prostate(1)|skin(2)	35	Lung SC(675;0.225)					CCAACCAGGGCGGGTGCCCCA	0.567		NA							Wilms' tumor-Aniridia-ambiguous Genitals-mental Retardation					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													135	133	134	NA		NA	NA	11		NA											NA				31822286		2202	4299	6501	SO:0001583	missense	Familial Cancer Database	WAGR syndrome	ENSG00000007372	HGNC:8620	NM_001604	Approved	uc021qfm.1	NA	Q6N006|Q99413	ENST00000419022.1	37	CCDS31452.1	.	.	.	.	.	.	.	.	.	.	C	13.45	2.242008	0.39598	.	.	ENSG00000007372	ENST00000419022;ENST00000379132;ENST00000379129;ENST00000379107;ENST00000241001;ENST00000379115;ENST00000379111;ENST00000379123;ENST00000494377;ENST00000470027;ENST00000379109;ENST00000533333;ENST00000531910;ENST00000471303;ENST00000455099;ENST00000481563	D;D;D;D;D;D;D;D;D;D;D;D;D;D;D	0.99070	-3.29;-3.31;-3.29;-3.29;-3.31;-3.29;-3.31;-3.31;-2.72;-2.72;-3.31;-3.04;-2.7;-3.54;-5.39	4.35	4.35	0.52113	.	0.238171	0.43260	D	0.000600	D	0.96762	0.8943	N	0.21373	0.66	0.58432	D	0.999998	P;B	0.45569	0.861;0.003	B;B	0.44224	0.444;0.002	D	0.96520	0.9385	10	0.15499	T	0.54	.	16.845	0.85978	0.0:1.0:0.0:0.0	.	173;159	F1T0F8;P26367	.;PAX6_HUMAN	H	173;159;173;173;159;173;159;159;23;23;159;114;23;23;106;23	ENSP00000404100:R173H;ENSP00000368427:R159H;ENSP00000368424:R173H;ENSP00000368401:R173H;ENSP00000241001:R159H;ENSP00000368410:R173H;ENSP00000368406:R159H;ENSP00000368418:R159H;ENSP00000451901:R23H;ENSP00000450775:R23H;ENSP00000368403:R159H;ENSP00000451372:R114H;ENSP00000452558:R23H;ENSP00000435884:R23H;ENSP00000397384:R106H	ENSP00000241001:R159H	R	-	2	0	PAX6	31778862	1.000000	0.71417	1.000000	0.80357	0.985000	0.73830	5.612000	0.67681	2.130000	0.65690	0.561000	0.74099	CGC	PAX6-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000099286.3	83.850941	KEEP		-	90.083133	0.262295	32	90	---	---	---	---	1	1	39	115	0	129	32	99	0	231	2	TP
ERBB3	2065	broad.mit.edu	37	12	56495025	56495025	+	Missense_Mutation	SNP	G	G	A			STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	g.chr12:56495025G>A	ENST00000267101.3	+	27	3822	c.3382G>A	c.(3382-3384)Gga>Aga	p.G1128R	ERBB3_ENST00000450146.2_Missense_Mutation_p.G485R|ERBB3_ENST00000415288.2_Missense_Mutation_p.G1069R|RP11-603J24.9_ENST00000548861.1_5'Flank|ERBB3_ENST00000553131.1_Missense_Mutation_p.G369R|ERBB3_ENST00000549832.1_Missense_Mutation_p.G248R	NM_001982.3	NP_001973.2	P21860	ERBB3_HUMAN	v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3	1128		NA			cranial nerve development|heart development|negative regulation of cell adhesion|negative regulation of neuron apoptosis|negative regulation of secretion|negative regulation of signal transduction|neuron apoptosis|phosphatidylinositol 3-kinase cascade|positive regulation of phosphatidylinositol 3-kinase cascade|regulation of cell proliferation|Schwann cell differentiation|transmembrane receptor protein tyrosine kinase signaling pathway|wound healing	basolateral plasma membrane|extracellular space|integral to plasma membrane|receptor complex	ATP binding|growth factor binding|protein heterodimerization activity|protein homodimerization activity|protein tyrosine kinase activator activity|receptor signaling protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity			central_nervous_system(2)|lung(3)|ovary(1)|skin(1)|stomach(1)	8			OV - Ovarian serous cystadenocarcinoma(18;0.112)			ACGGCCACGCGGAGATAGCGC	0.587		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0													64	61	62	NA		NA	NA	12		NA											NA				56495025		2203	4300	6503	SO:0001583	missense				HGNC:3431		Approved	uc001sjh.3	NA	A8K6L6|B4DIK7|B4DV32|E9PDT8|Q9BUD7	ENST00000267101.3	37	CCDS31833.1	.	.	.	.	.	.	.	.	.	.	G	15.79	2.937813	0.52972	.	.	ENSG00000065361	ENST00000267101;ENST00000450146;ENST00000415288;ENST00000550070;ENST00000553131;ENST00000549832	T;T;T;T;T	0.79352	-1.1;-1.04;-1.09;-1.26;-1.01	6.03	6.03	0.97812	.	0.286917	0.30185	N	0.010218	T	0.72882	0.3516	N	0.19112	0.55	0.48236	D	0.999613	D;D;D	0.67145	0.993;0.993;0.996	P;P;P	0.49276	0.605;0.47;0.54	T	0.74328	-0.3701	10	0.45353	T	0.12	.	17.4736	0.87653	0.0:0.0:1.0:0.0	.	1069;248;1128	P21860-4;B3KWG5;P21860	.;.;ERBB3_HUMAN	R	1128;485;1069;251;369;248	ENSP00000267101:G1128R;ENSP00000399178:G485R;ENSP00000408340:G1069R;ENSP00000449129:G369R;ENSP00000448729:G248R	ENSP00000267101:G1128R	G	+	1	0	ERBB3	54781292	1.000000	0.71417	0.984000	0.44739	0.944000	0.59088	5.093000	0.64517	2.861000	0.98227	0.655000	0.94253	GGA	ERBB3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000407619.3	36.42223	KEEP		+	39.780969	0.245614	14	43	---	---	---	---	1	1	96	206	3	264	16	49	0	78	10	TP
CIC	23152	broad.mit.edu	37	19	42793486	42793486	+	Missense_Mutation	SNP	G	G	A			STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-HU-A4GU-Tumor-SM-3UUOZ	STAD-TCGA-HU-A4GU-Normal-SM-3UUQI	g.chr19:42793486G>A	ENST00000572681.2	+	9	4083	c.4015G>A	c.(4015-4017)Gcc>Acc	p.A1339T	CIC_ENST00000575354.2_Missense_Mutation_p.A430T|CIC_ENST00000160740.3_Missense_Mutation_p.A430T			Q96RK0	CIC_HUMAN	capicua transcriptional repressor	430		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|protein binding			autonomic_ganglia(1)|breast(5)|central_nervous_system(32)|endometrium(10)|kidney(2)|large_intestine(7)|lung(9)|ovary(7)|prostate(3)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(2)	82		Prostate(69;0.00682)				TCAGCGTGCGGCCAGTGAGGA	0.627		NA	"""Mis, F, S"""		oligodendroglioma									NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Rec	yes		19	19q13.2	23152	capicua homolog		O	0													57	48	51	NA		NA	NA	19		NA											NA				42793486		2203	4300	6503	SO:0001583	missense			ENSG00000079432	HGNC:14214		Approved	uc002otf.1	NA	Q7LGI1|Q9UEG5|Q9Y6T1	ENST00000572681.2	37		.	.	.	.	.	.	.	.	.	.	G	18.00	3.525481	0.64860	.	.	ENSG00000079432	ENST00000160740	.	.	.	4.59	4.59	0.56863	.	.	.	.	.	T	0.33990	0.0882	N	0.14661	0.345	0.35455	D	0.796043	P	0.47409	0.895	B	0.41236	0.351	T	0.53450	-0.8437	8	0.87932	D	0	-19.6294	15.2624	0.73634	0.0:0.0:1.0:0.0	.	430	Q96RK0	CIC_HUMAN	T	430	.	ENSP00000160740:A430T	A	+	1	0	CIC	47485326	1.000000	0.71417	0.996000	0.52242	0.902000	0.53008	3.239000	0.51360	2.551000	0.86045	0.561000	0.74099	GCC	CIC-002	NOVEL	NAGNAG_splice_site|not_organism_supported|basic|exp_conf	protein_coding	NA	protein_coding	OTTHUMT00000438528.3	9.256276	KEEP		+	12.197346	0.172414	5	24	---	---	---	---	1	0.9999994	55	324	0	197	5	24	0	40	2	TP
